Blog

  • GLP-1s and Nutrition: What You Need to Know

    FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]

    Learn More

  • Designing Your Weight Loss Journey Around Healthy Habits

    While GLP-1 medication provides a phenomenal jumpstart for a weight loss journey, an integral part of achieving long-term results is developing healthy habits along the way. Diet and exercise are two common goals people set to improve, […]

    Learn More

  • The Landscape of Weight Loss Medications: An Overview

    The Landscape of Weight Loss Medications: An Overview

    FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]

    Learn More

  • Tirzepatide for Weight Loss

    Tirzepatide for Weight Loss

    FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]

    Learn More

  • Exercise and Its Role in Metabolic Weight Loss: Tips from the Clinic

    Exercise and Its Role in Metabolic Weight Loss: Tips from the Clinic

    Introduction to Metabolic Weight Loss Metabolic weight loss delves deeper than the surface-level concept of “calories in versus calories out” that’s often associated with traditional weight loss methods. Instead, it focuses on optimizing the body’s metabolic rate—the […]

    Learn More

  • The Role of a Weight Loss Prescription in Combating Obesity Epidemic

    The Role of a Weight Loss Prescription in Combating Obesity Epidemic

    Introduction We live in a culture that is characterized by sedentary routines and a prevalence of high-calorie, easily accessible foods. Due to this, the obesity epidemic has emerged as a critical global issue. Its ramifications are far-reaching, […]

    Learn More

  • FAQs on Semaglutide Dosage for Weight Loss

    FAQs on Semaglutide Dosage for Weight Loss

    Introduction to Semaglutide Semaglutide (the active ingredient in Wegovy® and Ozempic®) is a relatively newer addition to the arsenal of medications designed to manage metabolic conditions. It originated as a treatment for Type 2 diabetes and now […]

    Learn More

  • Introduction to Semaglutide Dosage

    Introduction to Semaglutide Dosage

    What is Semaglutide? Semaglutide (the active ingredient in Wegovy® and Ozempic®) is a revolutionary medication primarily developed for the management of type 2 diabetes. Now, it is an FDA approved treatment of obesity as well. As a […]

    Learn More

  • Finding the Right Online Prescription Weight Loss Specialist

    Finding the Right Online Prescription Weight Loss Specialist

    FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]

    Learn More

  • Combining GLP-1 weight loss with Diet and Exercise: A Powerful Weight Loss Strategy

    Combining GLP-1 weight loss with Diet and Exercise: A Powerful Weight Loss Strategy

    FDA notice on Zepbound®/Mounjaro® shortage: On October 2, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, had ended. (Read more) Schedule a visit with an Ivim […]

    Learn More